143 related articles for article (PubMed ID: 32424554)
1. Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes.
do Patrocinio AB; Cabral FJ; Bitencourt ALB; Brigato OM; Magalhães LG; de Lima Paula LA; Franco L; Guerra-Sá And R; Rodrigues V
Parasitol Res; 2020 Jul; 119(7):2159-2176. PubMed ID: 32424554
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinating enzymes as possible drug targets for schistosomiasis.
Barban do Patrocínio A; Cabral FJ; de Paiva TH; Magalhães LG; Paula LAL; Brigato OM; Guerra-Sá R; Rodrigues V
Acta Trop; 2021 May; 217():105856. PubMed ID: 33577811
[TBL] [Abstract][Full Text] [Related]
3. The role of 19S proteasome associated deubiquitinases in activity-dependent hippocampal synaptic plasticity.
Yun D; Zhuang Y; Kreutz MR; Behnisch T
Neuropharmacology; 2018 May; 133():354-365. PubMed ID: 29407217
[TBL] [Abstract][Full Text] [Related]
4. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
[TBL] [Abstract][Full Text] [Related]
5. Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma.
Jiang L; Sun Y; Wang J; He Q; Chen X; Lan X; Chen J; Dou QP; Shi X; Liu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):453. PubMed ID: 31694672
[TBL] [Abstract][Full Text] [Related]
6. The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage.
Zhang X; Pellegrini P; Saei AA; Hillert EK; Mazurkiewicz M; Olofsson MH; Zubarev RA; D'Arcy P; Linder S
Biochem Pharmacol; 2018 Oct; 156():291-301. PubMed ID: 30149015
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization and role of the proteasome in the oxidative stress response of adult Schistosoma mansoni worms.
de Paula RG; Ornelas AM; Morais ER; Borges Wde C; Natale M; Magalhães LG; Rodrigues V
Parasitol Res; 2014 Aug; 113(8):2887-97. PubMed ID: 24870249
[TBL] [Abstract][Full Text] [Related]
8. The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells.
Schmidt M; Altdörfer V; Schnitte S; Fuchs AR; Kropp KN; Maurer S; Müller MR; Salih HR; Rittig SM; Grünebach F; Dörfel D
Neoplasia; 2019 Jul; 21(7):653-664. PubMed ID: 31132676
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteasome deubiquitinating activity as a new cancer therapy.
D'Arcy P; Brnjic S; Olofsson MH; Fryknäs M; Lindsten K; De Cesare M; Perego P; Sadeghi B; Hassan M; Larsson R; Linder S
Nat Med; 2011 Nov; 17(12):1636-40. PubMed ID: 22057347
[TBL] [Abstract][Full Text] [Related]
10. Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni.
Morais ER; Oliveira KC; Paula RG; Ornelas AMM; Moreira ÉBC; Badoco FR; Magalhães LG; Verjovski-Almeida S; Rodrigues V
PLoS One; 2017; 12(9):e0184192. PubMed ID: 28898250
[TBL] [Abstract][Full Text] [Related]
11. Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress.
Brnjic S; Mazurkiewicz M; Fryknäs M; Sun C; Zhang X; Larsson R; D'Arcy P; Linder S
Antioxid Redox Signal; 2014 Dec; 21(17):2271-85. PubMed ID: 24011031
[TBL] [Abstract][Full Text] [Related]
12. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X
Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333
[TBL] [Abstract][Full Text] [Related]
13. The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death.
Wang X; Stafford W; Mazurkiewicz M; Fryknäs M; Brjnic S; Zhang X; Gullbo J; Larsson R; Arnér ES; D'Arcy P; Linder S
Mol Pharmacol; 2014 Jun; 85(6):932-45. PubMed ID: 24714215
[TBL] [Abstract][Full Text] [Related]
14. Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with
Jiang ZY; Hong J; Zhang JH; Wang XF; Ma YS; Xiong ZX; Sun HR; Cheng C; Xie BZ; Liu JB; Ouyang YG; Fu D
Technol Cancer Res Treat; 2022; 21():15330338221119745. PubMed ID: 35971329
[No Abstract] [Full Text] [Related]
15. Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.
Hillert EK; Brnjic S; Zhang X; Mazurkiewicz M; Saei AA; Mofers A; Selvaraju K; Zubarev R; Linder S; D'Arcy P
Cancer Lett; 2019 Apr; 448():70-83. PubMed ID: 30768956
[TBL] [Abstract][Full Text] [Related]
16. A ubiquitinome analysis to study the functional roles of the proteasome associated deubiquitinating enzymes USP14 and UCH37.
van der Wal L; Bezstarosti K; Demmers JAA
J Proteomics; 2022 Jun; 262():104592. PubMed ID: 35489684
[TBL] [Abstract][Full Text] [Related]
17. Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition.
Patel K; Ahmed ZS; Huang X; Yang Q; Ekinci E; Neslund-Dudas CM; Mitra B; Elnady FA; Ahn YH; Yang H; Liu J; Dou QP
Future Med Chem; 2018 Sep; 10(17):2087-2108. PubMed ID: 30066579
[TBL] [Abstract][Full Text] [Related]
18. MJD and OTU deubiquitinating enzymes in Schistosoma mansoni.
Pereira RV; Gomes Mde S; Costa MP; Passos LK; Borges Wde C; Guerra-Sá R
Parasitol Res; 2015 Aug; 114(8):2835-43. PubMed ID: 25924794
[TBL] [Abstract][Full Text] [Related]
19. Proteasome stress responses in Schistosoma mansoni.
de Paula RG; de Magalhães Ornelas AM; Morais ER; de Souza Gomes M; de Paula Aguiar D; Magalhães LG; Rodrigues V
Parasitol Res; 2015 May; 114(5):1747-60. PubMed ID: 25663105
[TBL] [Abstract][Full Text] [Related]
20. Smp38 MAP Kinase Regulation in
Avelar LDGA; Gava SG; Neves RH; Silva MCS; Araújo N; Tavares NC; Khal AE; Mattos ACA; Machado-Silva JR; Oliveira G; Mourão MM
Front Immunol; 2019; 10():21. PubMed ID: 30733716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]